Join the club for FREE to access the whole archive and other member benefits.

Robert Brooke

Bioengineer & biotech entrepreneur, CEO, CTO and Co-founder at Intervene Immune

Robert (Bobby) Brooke obtained his MS in Biomedical Engineering from UCLA in 2005.  After graduating, Mr. Brooke worked in healthcare finance with an investment firm in Westwood before starting a career as a biotech entrepreneur.  He has founded multiple companies including an immunotherapy company now known as Iovance Biotherapeutics, a cannabinoid drug developer named Vitality Biopharma, and most recently Intervene Immune, which is focused on the prevention or reversal of age-related immune system decline.  In 2019, Intervene Immune published clinical trial results with UCLA and Stanford collaborators demonstrating reversal of immunosenescent trends, and also the first ever reversal of epigenetic aging, which is the most accurate measure of biological age available today.

Visit website:



See also: Company Intervene Immune - Company focused on the age-related decline of the immune system, which is known as immunosenescence

Details last updated 09-Mar-2023

Robert Brooke is also referenced in the following:

Rejuvenation Startup Summit 2024

10-May-2024 to 11-May-2024

The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation